NPIP will transform medical research and provide better outcomes for patients. The Medicines Discovery Catapult (MDC), the Medical Research Council (MRC) and Innovative UK have …

The study used data from 50,000 people in the UK Biobank. AstraZeneca (AZ) researchers have revealed thousands of associations between rare genetic variants and plasma …

DD2023 #ELRIG #drugdiscovery23 The most important drug discovery event of the year is just around the corner!  ELRIG (The European Laboratory Research & Innovation Group) …

Last week, AbbVie reported findings from its phase 3 study, evaluating venetoclax combined with dexamethasone (VenDex) in patients with multiple myeloma who had undergone two or more …

NIHR awards £97.5m to fund its new Research Support Service. The National Institute for Health and Care Research (NIHR) has announced the launch of its …

The Cancer Hub aims to create a world-leading ecosystem for cancer research. Vortex Biosciences has expanded its liquid biopsy research at the London Cancer Hub’s …

The proposed changes could limit patients’s access to treatments and clinical trials. The National Economic Research Associates (NERA) Economic Consulting has raised concerns about the …

The study analysed and compared information from 65,000 MS patients. A new study conducted by the MS Society has revealed why people living with multiple …

ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce the appointment of Borja Guerra …

EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate. Oxford BioDynamics – a company developing precision medicine tests …